Advertisement
Advertisement
ATRA
Atara Biotherapeutics, Inc
8.10
USDSponsored
-0.08
-0.98%
Nov 10, 15:59 UTC -5
Closed
After-Market
7.98
-0.12
-1.48%
Atara Biotherapeutics, Inc (ATRA)
Atara Biotherapeutics, Inc Financial Snapshot
| Market Cap | 80.10M |
| Beta | 0.28 |
| Earnings Per Share (EPS) | -1.18 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -269.42% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 1.98% |
| Free Cash Flow | -6.41M |
